National Institute of Biomedical Imaging and Bioengineering; Notice of Closed Meeting, 10375 [2022-03888]
Download as PDF
<![CDATA[
Federal Register / Vol. 87, No. 37 / Thursday, February 24, 2022 / Notices
www.fda.gov/regulatory-information/
search-fda-guidance-documents,
https://www.fda.gov/emergencypreparedness-and-response/
coronavirus-disease-2019-covid-19/
covid-19-related-guidance-documentsindustry-fda-staff-and-otherstakeholders, or https://
www.regulations.gov.
Bethesda, MD 20892, 301–496–6455,
rneumann@cc.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Dated: February 16, 2022.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2022–03915 Filed 2–23–22; 8:45 am]
Dated: February 18, 2022.
Patricia B. Hansberger,
Supervisory Program Analyst, Office of
Federal Advisory Committee Policy.
BILLING CODE 4164–01–P
[FR Doc. 2022–03946 Filed 2–23–22; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institutes of Health
Clinical Center; Notice of Closed
Meeting
jspears on DSK121TN23PROD with NOTICES1
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the Board of Scientific
Counselors of the NIH Clinical Center.
The meeting will be closed to the
public as indicated below in accordance
with the provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended for the review, discussion,
and evaluation of individual intramural
programs and projects conducted by the
CLINICAL CENTER, including
consideration of personnel
qualifications and performance, and the
competence of individual investigators,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Board of Scientific
Counselors of the NIH Clinical Center.
Date: March 28, 2022.
Time: 10:00 a.m. to 4:45 p.m.
Agenda: To review and evaluate
department of Perioperative Medicine Pain
and Palliative Care Service and Interviews.
Place: Clinical Center, National Institutes
of Health, 10 Center Drive, Bethesda, MD
20892 (Virtual Meeting).
Contact Person: Ronald Neumann, MD,
Senior Investigation, Clinical Center,
National Institutes of Health, 10 Center Drive,
Bethesda, MD 20892, 301–496–6455,
rneumann@cc.nih.gov.
Name of Committee: Board of Scientific
Counselors of the NIH Clinical Center.
Date: March 29, 2022.
Time: 10:30 a.m. to 12:30 p.m.
Agenda: To review and evaluate
department of Perioperative Medicine Pain
and Palliative Care Service and Interviews.
Place: Clinical Center, National Institutes
of Health, 10 Center Drive, Bethesda, MD
20892 (Virtual Meeting).
Contact Person: Ronald Neumann, MD,
Senior Investigation, Clinical Center,
National Institutes of Health, 10 Center Drive,
VerDate Sep<11>2014
16:46 Feb 23, 2022
Jkt 256001
National Institute of Biomedical
Imaging and Bioengineering; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Institute of
Biomedical Imaging and Bioengineering
Special Emphasis Panel. The meetings
will be closed to the public in
accordance with the provisions set forth
in sections 552b(c)(4) and 552b(c)(6),
Title 5 U.S.C., as amended. The grant
applications and the discussions could
disclose confidential trade secrets or
commercial property such as patentable
material, and personal information
concerning individuals associated with
the grant applications, the disclosure of
which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: National Institute of
Biomedical Imaging and Bioengineering
Special Emphasis Career Development (Ks)
and Conference support (R13) Review.
Date: March 17, 2022.
Time: 10:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Democracy II, 6707 Democracy Blvd.,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Songtao Liu, MD,
Scientific Review Officer, National Institute
of Biomedical Imaging and Bioengineering,
National Institutes of Health, 6707
Democracy Blvd., Suite 920, Bethesda, MD
20892, (301) 827–3025, songtao.liu@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, National Institute of
Biomedical Imaging and Bioengineering,
National Institutes of Health, HHS)
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
10375
Dated: February 17, 2022.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–03888 Filed 2–23–22; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
Federal Emergency Management
Agency
[Docket ID FEMA–2022–0002; Internal
Agency Docket No. FEMA–B–2216]
Changes in Flood Hazard
Determinations
Federal Emergency
Management Agency, Department of
Homeland Security.
ACTION: Notice.
AGENCY:
This notice lists communities
where the addition or modification of
Base Flood Elevations (BFEs), base flood
depths, Special Flood Hazard Area
(SFHA) boundaries or zone
designations, or the regulatory floodway
(hereinafter referred to as flood hazard
determinations), as shown on the Flood
Insurance Rate Maps (FIRMs), and
where applicable, in the supporting
Flood Insurance Study (FIS) reports,
prepared by the Federal Emergency
Management Agency (FEMA) for each
community, is appropriate because of
new scientific or technical data. The
FIRM, and where applicable, portions of
the FIS report, have been revised to
reflect these flood hazard
determinations through issuance of a
Letter of Map Revision (LOMR), in
accordance with Federal Regulations.
The currently effective community
number is shown in the table below and
must be used for all new policies and
renewals.
DATES: These flood hazard
determinations will be finalized on the
dates listed in the table below and
revise the FIRM panels and FIS report
in effect prior to this determination for
the listed communities.
From the date of the second
publication of notification of these
changes in a newspaper of local
circulation, any person has 90 days in
which to request through the
community that the Deputy Associate
Administrator for Insurance and
Mitigation reconsider the changes. The
flood hazard determination information
may be changed during the 90-day
period.
ADDRESSES: The affected communities
are listed in the table below. Revised
SUMMARY:
E:\FR\FM\24FEN1.SGM
24FEN1
]]>Agencies
[Federal Register Volume 87, Number 37 (Thursday, February 24, 2022)]
[Notices]
[Page 10375]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-03888]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Biomedical Imaging and Bioengineering;
Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the National Institute
of Biomedical Imaging and Bioengineering Special Emphasis Panel. The
meetings will be closed to the public in accordance with the provisions
set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as
amended. The grant applications and the discussions could disclose
confidential trade secrets or commercial property such as patentable
material, and personal information concerning individuals associated
with the grant applications, the disclosure of which would constitute a
clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Biomedical Imaging and
Bioengineering Special Emphasis Career Development (Ks) and
Conference support (R13) Review.
Date: March 17, 2022.
Time: 10:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Democracy II, 6707
Democracy Blvd., Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Songtao Liu, MD, Scientific Review Officer,
National Institute of Biomedical Imaging and Bioengineering,
National Institutes of Health, 6707 Democracy Blvd., Suite 920,
Bethesda, MD 20892, (301) 827-3025, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.866,
National Institute of Biomedical Imaging and Bioengineering,
National Institutes of Health, HHS)
Dated: February 17, 2022.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-03888 Filed 2-23-22; 8:45 am]
BILLING CODE 4140-01-P
